On September 15, 2019, the Center for Medicare Advocacy (the Center) and the Long Term Care Community Coalition (LTCCC) submitted comments opposing the Trump Administration’s proposed rule to revise the nursing home Requirements of Participation. The proposed rule is the latest example of the Administration’s efforts to deregulate the nursing home industry. Among the changes, the Centers for Medicare & Medicaid Services (CMS) is proposing to make it easier for facilities to administer antipsychotic drugs to residents, despite decades of reporting indicating the widespread and inappropriate use of such drugs. The Center and LTCCC believe that the proposed rule, if finalized, will endanger the health, safety, and wellbeing of residents across the country.
The Center and LTCCC submitted comments on behalf of our, and the following, organizations:
- Alliance of New York Family Councils
- The American Occupational Therapy Association
- The American Physical Therapy Association
- Center for Independence of the Disabled, New York
- Christopher & Dana Reeve Foundation
- Disabled in Action of Greater Syracuse Inc.
- Disability Rights Education and Defense Fund
- Elder Justice Committee of Metro Justice
- Friends of Residents in Long-Term Care (North Carolina)
- Gray Panthers NYC
- Greater Boston Legal Services, Elder, Health and Disability Unit, on Behalf of Our Clients
- Health Care For All New York
- Kansas Advocates for Better Care
- Massachusetts Advocates for Nursing Home Reform
- Mobilization for Justice, Inc.
- National Academy of Elder Law Attorneys
- The National Assn of County Behavioral Health and Developmental Disability Directors
- New York Lawyers for the Public Interest
To read our joint comments, please visit https://www.medicareadvocacy.org/center-comments-on-proposed-rule-to-revise-nursing-home-requirements-of-participation/. For additional information about Medicare and nursing home care, please visit: https://www.medicareadvocacy.org/medicare-info/skilled-nursing-facility-snf-services/.
September 19, 2019 – D. Valanejad